• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl).

作者信息

Pogglitsch H, Petek W, Waller J, Stübchen-Kirchner H

出版信息

Wien Klin Wochenschr. 1977 Dec 23;89(24):812-9.

PMID:595605
Abstract

Substances causing blood pressure changes and myocardial damage in rats were first detected in the ultrafiltrate obtained from patients on long-term haemodialysis by means of size separation, high-voltage electrophoresis and thin-layer chromatography. Of the 100 to 140 fractions produced by Sephadex G 15 chromatography at least 3 raised the blood pressure when administered in doses of 2 to 10 mg/0.1 to 0.2 ml 0.9% NaCl, that is the high molecular fraction 18 to 23 and the low molecular fractions 71 to 72 and 73 to 74. The fractions 96 to 98 and 97 to 106 showed high toxicity. Less than 1 mg/0.1 to 0.2 ccm 0.9% NaCl produced cardiac arrest. The fractions 35 to 55, which originate from the middle molecules and are retained in regularly uraemia, contain substances which caused a reduction in blood pressure at low dosage and cardiotoxic effects at a dosage of more than 10 mg. Thin-layer chromatography indicates that the substances most probably consist of peptides whose structure contains the amino acids leucine, isoleucine, valine, glutamic acid, aspartic acid, alanine and cystine.

摘要

相似文献

1
Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl).
Wien Klin Wochenschr. 1977 Dec 23;89(24):812-9.
2
Middle molecules in uremic serum, urine and dialysis fluid.尿毒症血清、尿液和透析液中的中分子物质。
Clin Nephrol. 1975;3(3):82-93.
3
[Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].[应用高效液相色谱法和薄层层析法对尿毒症患者血浆中分子质量组分的研究]
Vopr Med Khim. 1988 Nov-Dec;34(6):23-6.
4
[Middle molecules separation from uraemic serum (author's transl)].从尿毒症血清中分离中分子物质(作者译)
Ateneo Parmense Acta Biomed. 1975 Sep-Oct;46(5):331-44.
5
[An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
Pol Merkur Lekarski. 1996 Oct;1(4):246-8.
6
Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
Artif Organs. 1981;4 Suppl:17-21.
7
Ultrafiltration for middle molecules in uraemia.尿毒症中分子物质的超滤治疗
Proc Eur Dial Transplant Assoc. 1975;11:158-64.
8
Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability.透析中低血压前交感神经反应受损:一项基于心率和血压变异性频谱分析的研究。
Clin Sci (Lond). 1999 Jan;96(1):23-31.
9
Blood level of middle molecular substances during uraemia and haemodialysis.尿毒症及血液透析期间中分子物质的血药浓度
Proc Eur Dial Transplant Assoc. 1973;10(0):263-70.
10
Characterization of middle molecule compounds.中分子化合物的表征
Artif Organs. 1981;4 Suppl:33-6.